Skip to main content
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience 6/2019

06.08.2019 | Editorial

Corticosteroid-induced psychiatric disorders: genetic studies are needed

verfasst von: Florence Thibaut

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Excerpt

Glucocorticoids are steroid hormones, secreted by the adrenal glands, that bind with high affinity to brain mineralocorticoid receptors (MR) and lower affinity to glucocorticoid receptors (GR). GR are widely distributed throughout the brain, whereas MR are mainly found in the hippocampus. Cortisol exerts predominantly its tonic influences via hippocampal MR, whereas feedback actions at the level of the pituitary as well as actions at the amygdala level are mediated by GR. In addition, glucocorticoid responsive elements are found in the regulatory regions of many genes in the brain. Glucocorticoids are involved in different processes such as glucose metabolism, inflammation, immunity, etc. The stress responsive hypothalamic pituitary adrenal (HPA) axis regulates glucocorticoid production and is implicated in the pathophysiology of anxiety and depression as well as in cognitive functioning or the development and relapse of psychotic disorders. Major depression may be associated with a dysregulation of MR and/or GR within the HPA axis; elevated HPA activity could be more often associated with depression with psychotic features. Elevated cortisol secretion has also been positively linked with symptom severity in people with psychotic disorders. Antiglucocorticoid and related drugs that target the HPA axis may be useful for the treatment of people with psychosis and were also studied in the treatment of depressive disorders or in the improvement of cognitive dysfunction associated with these disorders [1]. Moreover, inflammation plays a significant role in the pathophysiology of major psychiatric disorders. …
Literatur
1.
Zurück zum Zitat Soria V, González-Rodríguez A, Huerta-Ramos E, Usall J, Cobo J, Bioque M, Barbero JD, García-Rizo C, Tost M, Monreal JA, PNECAT Group, Labad J (2018) Targeting hypothalamic-pituitary-adrenal axis hormones and sex steroids for improving cognition in major mood disorders and schizophrenia: a systematic review and narrative synthesis. Psychoneuroendocrinology 93:8–19. https://doi.org/10.1016/j.psyneuen.2018.04.012 CrossRefPubMed Soria V, González-Rodríguez A, Huerta-Ramos E, Usall J, Cobo J, Bioque M, Barbero JD, García-Rizo C, Tost M, Monreal JA, PNECAT Group, Labad J (2018) Targeting hypothalamic-pituitary-adrenal axis hormones and sex steroids for improving cognition in major mood disorders and schizophrenia: a systematic review and narrative synthesis. Psychoneuroendocrinology 93:8–19. https://​doi.​org/​10.​1016/​j.​psyneuen.​2018.​04.​012 CrossRefPubMed
2.
Zurück zum Zitat Dubovsky AN, Arvikar S, Stern TA, Axelrod L (2012) The neuropsychiatric complications of glucocorticoid use: steriod psychosis revisited. Psychosomatics 53:103–115CrossRefPubMed Dubovsky AN, Arvikar S, Stern TA, Axelrod L (2012) The neuropsychiatric complications of glucocorticoid use: steriod psychosis revisited. Psychosomatics 53:103–115CrossRefPubMed
3.
Zurück zum Zitat Lewis DA, Smith RE (1983) Steroid-induced psychiatric syndromes. A report of 14 cases and a review of the literature. J Affect Disord 5(4):319–332CrossRefPubMed Lewis DA, Smith RE (1983) Steroid-induced psychiatric syndromes. A report of 14 cases and a review of the literature. J Affect Disord 5(4):319–332CrossRefPubMed
5.
Zurück zum Zitat Rasmusson AM, Marx CE, Pinelesa SL, Loccie A, Scioli-Salter ER, Nillnia YI, Liang JJ, Pinnae G (2017) Neuroactive steroids and PTSD treatment. Neurosci Lett 649:156–163CrossRefPubMed Rasmusson AM, Marx CE, Pinelesa SL, Loccie A, Scioli-Salter ER, Nillnia YI, Liang JJ, Pinnae G (2017) Neuroactive steroids and PTSD treatment. Neurosci Lett 649:156–163CrossRefPubMed
6.
Zurück zum Zitat Wolkowitz OM, Rubinow D, Doran AR, Breier A, Berrettini WH, Kling MA (1990) Prednisone effects on neurochemistry and behavior. Preliminary findings. Arch Gen Psychiatry 47:963–968CrossRefPubMed Wolkowitz OM, Rubinow D, Doran AR, Breier A, Berrettini WH, Kling MA (1990) Prednisone effects on neurochemistry and behavior. Preliminary findings. Arch Gen Psychiatry 47:963–968CrossRefPubMed
8.
Zurück zum Zitat Brown ES, Sayeda N, Choic C, Tustisond N, Robertsd J, Yassad MA, Van Enkevorta E, Nakamuraa A, Ivlevaa EI, Sunderajana P, Khanb DA, Vazquez M, McEwen B, Kulikovaa A, Frola AB, Holmesa T (2019) A randomized, double-blind, placebo-controlled trial of lamotrigine for prescription corticosteroid effects on the human hippocampus. Eur Neuropsychopharmacol 29:376–383CrossRefPubMed Brown ES, Sayeda N, Choic C, Tustisond N, Robertsd J, Yassad MA, Van Enkevorta E, Nakamuraa A, Ivlevaa EI, Sunderajana P, Khanb DA, Vazquez M, McEwen B, Kulikovaa A, Frola AB, Holmesa T (2019) A randomized, double-blind, placebo-controlled trial of lamotrigine for prescription corticosteroid effects on the human hippocampus. Eur Neuropsychopharmacol 29:376–383CrossRefPubMed
9.
Zurück zum Zitat Schijvens AM, Heine R, de Wildt SN, Schreuder MF (2019) Pharmacology and pharmacogenetics of prednisone and prednisolone in patients with nephrotic syndrome. Pediatr Nephrol 34:389–403CrossRefPubMed Schijvens AM, Heine R, de Wildt SN, Schreuder MF (2019) Pharmacology and pharmacogenetics of prednisone and prednisolone in patients with nephrotic syndrome. Pediatr Nephrol 34:389–403CrossRefPubMed
Metadaten
Titel
Corticosteroid-induced psychiatric disorders: genetic studies are needed
verfasst von
Florence Thibaut
Publikationsdatum
06.08.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 6/2019
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-019-01049-2

Weitere Artikel der Ausgabe 6/2019

European Archives of Psychiatry and Clinical Neuroscience 6/2019 Zur Ausgabe

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.